Dynamic responses to leptin secretagogues in lean, obese, and massively obese men and women

Hormone Research

Volumn 70, Issue 3, 2008, Pages 174-181

  Dagogo Jack, Samuel ^a,c   Askari, Hasan ^b   Tykodi, Gunjan ^b   Liu, Jianmei ^b   Umamaheswaran, Indira ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Gender dimorphism; Glucocorticoids; Insulin; Leptin secretagogues; Obesity

Indexed keywords

C PEPTIDE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOSE; HYDROCORTISONE; INSULIN; LEPTIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE RELEASE; HORMONE RESISTANCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERINSULINEMIA; INGESTION; INSULIN INFUSION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN SECRETION; SEX DIFFERENCE;

ADULT; C-REACTIVE PROTEIN; DEXAMETHASONE; GLUCOCORTICOIDS; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIC AGENTS; INSULIN; LEPTIN; MALE; OBESITY; OBESITY, MORBID; SECRETORY RATE; SEX FACTORS;

EID: 47949090125     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000145018     Document Type: Article

References (38)

1. Considine RV, Sinha MK, Heiman ML, Kriaciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
2. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M: Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996;45:695-698.
3. Ostlund RE Jr, Yang JW, Klein S, Gingerich R: Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab 1996;81:3909-3913.
4. Lonnqvist F, Aener P, Nordfors L, Schalling M: Overexpression of the obese (ob) gene in adipose tissue of obese subjects. Nat Med 1995;1:950-953.
5. Hamilton BS, Paglia D, Kwan AYM, Deitel M: Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995;1:953-956.
6. Levy JR, Gyarmati J, Lesko JM, Adler RA, Stevens W: Dual regulation of leptin secretion: intracellular energy and calcium dependence of regulated pathway. Am J Physiol Endocrinol Metab 2000;278:E892-E901.
7. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995;1:1311-1314.
8. Schwartz MW, Peskind E, Boyko EJ, Porte D Jr: Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996;2:589-593.
9. Blorbaek C, El-Haschimi K, Fratz JD, Flier JS: The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 1996;274:30059-30065.
10. Steinberg GR, McAinch AJ, Chen MB, O'Brien PE, Dixon JB, Cameron-Smith D, Kemp BE: The suppressor of cytokine signalling 3 (SOCS3) inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab 2006;91:3592-3597.
11. Dagogo-Jack S, Santiago JV: Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med 1997;157:1802-1817.
12. Weyer C, Bogardus C, Mott, DM, Pratley RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes. J Clin Invest 1999;104:787-794.
13. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Daily G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. JAMA 1995;273:1855-1861.
14. Pfeifer MA, Halter JB, Porte D Jr: Insulin secretion in diabetes mellitus. Am J Med 1981;70:578-588.
15. Fernandez-Castaner M, Biarnes J, Camps I, Ripolles J, Gomez N, Soler J: Beta-cell dysfunction in first degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabet Med 1996;13:953-959.
16. Larsson H, Ahren B: Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab 1996;81:4428-4432.
17. Dagogo-Jack S, Selke G, Melson AK, Newcomer JW: Robust leptin secretory responses to dexamethasone in obese subjects. J Clin Endocrinol Metab 1997;82:3230-3233.
18. Papaspyrou-Rao S, Schneider SH, Petersen RN, Fried SK: Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 1997;82:1635-1637.
19. Saad MF, Khan A, Sharma A, Michael R, Riad-Gabriel MG, Boyadjian R, Jinagouda SD, Steil GM, Kamdar V: Physiological insulinemia acutely modulates plasma leptin. Diabetes 1998;47:544-549.
20. Askari H, Liu J, Dagogo-Jack S: Hormonal regulation of human leptin in vivo: effects of hydrocortisone and insulin. Int J Obes Relat Metab Disord 2000;24:1254-1259.
21. Boden G, Chen X, Mozzoli M, Ryan I: Effect of fasting on serum leptin in human subjects. J Clin Endocrinol Metab 1996;81:3419-3423.
22. Kolaczynski JW, Ohannesian JP, Considine RV, Marco CC, Caro JF: Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 1996;81:4162-4165.
23. Perusse L, Collier G, Gagnon J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Nadeau A, Zimmet PZ, Bouchard C: Acute and chronic effects of exercise on leptin levels in humans. J Appl Physiol 1997;83:5-10.
24. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197.
25. Liu J, Askari H, Dagogo-Jack S: Basal and stimulated plasma leptin in diabetic subjects. Obes Res 1999;7:537-544.
26. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M: Radioimmunoassay of leptin in human plasma. Clin Chem 1996;42:942-946.
27. Kuzuya H, Blix P, Horwitz D, Steiner D, Rubenstein A: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977;26:22-29.
28. Farmer R, Pierce C: Plasma cortisol determination. Radioimmunoassay and competitive binding compared. Clin Chem 1974;20:411-414.
29. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M: Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999;282:1568-1575.
30. Fogteloo AJ, Pijl H, Frölich M, McCamish M, Meinders AE: Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. Diabetes Nutr Metab 2003;16:109-114.
31. Leibel RL, Rosenbaum M, Hirsch J: Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995;332:621-628.
32. Dagogo-Jack S: Neuroendocrine regulation of food intake;in Opara E (ed): Diabetes and Nutrition. Boca Raton, CRC Press, 2006, pp 5-25.
33. Kirschbaum C, Bono EG, Rohleder N, Gessner C, Pirke KM, Salvador A, Hellhammer DH: Effects of fasting and glucose load on free cortisol responses to stress and nicotine. J Clin Endocrinol Metab 1997;82:1101-1105.
34. Laferrère B, Abraham C, Awad M, Jean-Baptiste S, Hart AB, Garcia-Lorda P, Kokkoris P, Russell CD: Inhibiting endogenous cortisol blunts the meal-entrained rise in serum leptin. J Clin Endocrinol Metab 2006;91:2232-2238.
35. Laferrère B, Fried SK, Hough K, Campbell SA, Thornton J, Pi-Sunyer FX: Synergistic effects of feeding and dexamethasone on serum leptin levels. J Clin Endocrinol Metab 1998;83:3742-3745.
36. Umamaheswaran I, Askari H, Tykodi G, Dagogo-Jack S: Plasma leptin response to glucocorticoid occurs at physiological doses, and is abolished by fasting. Obes Res 2003;11:232-237.
37. Dagogo-Jack S, Tykodi G, Umamaheswaran I: Inhibition of cortisol biosynthesis decreases circulating leptin levels in obese humans. J Clin Endocrinol Metab 2005;90:5333-5335.
38. Askari H, Liu J, Dagogo-Jack S: Energy adaptation to glucocorticoid- induced hyperleptinemia in human beings. Metabolism 2005;54:876-880.